PFCS
PASG icon

Pale Fire Capital SE’s Passage Bio PASG Stock Holding History

Pale Fire Capital SE’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,072
Closed -$191K – 59
2024
Q1 		$191K Sell
7,072
-21,991
-76% -$529K 0.03% 34
2023
Q4 		$587K Buy
29,063
+24,130
+489% +$333K 0.09% 33
2023
Q3 		$64.9K Hold
4,933
– – 0.01% 64
2023
Q2 		$92.9K Buy
+4,933
New +$97.6K 0.01% 45

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Pale Fire Capital SE's PASG Position: Q2 2024 in Review

Pale Fire Capital SE sold out of Passage Bio (PASG) in Q2 2024, closing a stake of 7,072 shares — an estimated $191K sold.

Pale Fire Capital SE first reported a position in PASG in Q2 2023 and held it in 4 quarters. The position peaked at $587K in Q4 2023. 43 funds tracked by Wall St. Rank hold PASG as of Q2 2024.

  • Pale Fire Capital SE reported no remaining Passage Bio position as of Q2 2024 after selling out during the quarter.
  • Pale Fire Capital SE sold 7,072 Passage Bio shares in Q2 2024, an estimated $191K.
  • Pale Fire Capital SE first reported a position in Passage Bio in Q2 2023 and held it in 4 quarters.
  • Pale Fire Capital SE's Passage Bio position peaked at $587K in Q4 2023.
  • 43 funds tracked by Wall St. Rank held Passage Bio as of Q2 2024.

Based on Pale Fire Capital SE's 13F filing for Q2 2024, filed 13 Aug 2024.